Cargando…

Factors predicting prolonged empirical antifungal treatment in critically ill patients

OBJECTIVE: To determine the incidence, risk factors, and impact on outcome of prolonged empirical antifungal treatment in ICU patients. METHODS: Retrospective observational study performed during a one-year period. Patients who stayed in the ICU >48 h, and received empirical antifungal treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zein, Mohamed, Parmentier-Decrucq, Erika, Kalaoun, Amer, Bouton, Olivier, Wallyn, Frédéric, Baranzelli, Anne, Elmanser, Dia, Sendid, Boualem, Nseir, Saad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984712/ https://www.ncbi.nlm.nih.gov/pubmed/24621182 http://dx.doi.org/10.1186/1476-0711-13-11

Ejemplares similares

De-escalation of antifungal treatment in critically ill patients with suspected invasive Candida infection: incidence, associated factors, and safety
por: Jaffal, Karim, et al.
Publicado: (2018)

The Changing Landscape of Invasive Fungal Infections in ICUs: A Need for Risk Stratification to Better Target Antifungal Drugs and the Threat of Resistance
por: Poissy, Julien, et al.
Publicado: (2022)

Adverse events during intrahospital transport of critically ill patients: incidence and risk factors
por: Parmentier-Decrucq, Erika, et al.
Publicado: (2013)

Impact of antifungal treatment on Candida–Pseudomonas interaction: a preliminary retrospective case–control study
por: Nseir, Saad, et al.
Publicado: (2006)

Hyperbaric hyperoxemia as a risk factor for ventilator-acquired pneumonia?
por: Caplan, Morgan, et al.
Publicado: (2021)

Efficiency of an electronic device in controlling tracheal cuff pressure in critically ill patients: a randomized controlled crossover study
por: Rouzé, Anahita, et al.
Publicado: (2016)

Antifungal stewardship in critically ill patients
por: De Pascale, Gennaro, et al.
Publicado: (2023)

Antifungal Properties of Hydrazine-Based Compounds against Candida albicans
por: Camaioni, Louis, et al.
Publicado: (2023)

Natural Compounds with Antifungal Properties against Candida albicans and Identification of Hinokitiol as a Promising Antifungal Drug
por: Camaioni, Louis, et al.
Publicado: (2023)

Oleic Acid and Palmitic Acid from Bacteroides thetaiotaomicron and Lactobacillus johnsonii Exhibit Anti-Inflammatory and Antifungal Properties
por: Charlet, Rogatien, et al.
Publicado: (2022)

Two New Compounds Containing Pyridinone or Triazine Heterocycles Have Antifungal Properties against Candida albicans
por: Mena, Laura, et al.
Publicado: (2022)

A Small Aromatic Compound Has Antifungal Properties and Potential Anti-Inflammatory Effects against Intestinal Inflammation
por: Bortolus, Clovis, et al.
Publicado: (2019)

Short term Candida albicans colonization reduces Pseudomonas aeruginosa-related lung injury and bacterial burden in a murine model
por: Ader, Florence, et al.
Publicado: (2011)

Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links
por: Sendid, Boualem, et al.
Publicado: (2006)

Attempts to Access a Series of Pyrazoles Lead to New Hydrazones with Antifungal Potential against Candida species including Azole-Resistant Strains
por: Negru, Georgiana, et al.
Publicado: (2021)

Clinical Impact of Antifungal Susceptibility, Biofilm Formation and Mannoside Expression of Candida Yeasts on the Outcome of Invasive Candidiasis in ICU: An Ancillary Study on the Prospective AmarCAND2 Cohort
por: Gangneux, Jean-Pierre, et al.
Publicado: (2018)

Empirical antifungal treatment in the critically ill patients: how does it impact on the outcome?
por: Bruyère, R, et al.
Publicado: (2012)

Need for expanded Candida Score for empiric antifungal use in medically critically ill patients?
por: Laine, Melanie E., et al.
Publicado: (2019)

Bacteroides thetaiotaomicron and Lactobacillus johnsonii modulate intestinal inflammation and eliminate fungi via enzymatic hydrolysis of the fungal cell wall
por: Charlet, Rogatien, et al.
Publicado: (2020)

Extracorporeal Membrane Oxygenation for COVID 2019-Acute Respiratory Distress Syndrome: Comparison between First and Second Waves (Stage 2)
por: Dognon, Nicolas, et al.
Publicado: (2021)

Polysaccharides Cell Wall Architecture of Mucorales
por: Lecointe, Karine, et al.
Publicado: (2019)

A decrease in anaerobic bacteria promotes Candida glabrata overgrowth while β-glucan treatment restores the gut microbiota and attenuates colitis
por: Charlet, Rogatien, et al.
Publicado: (2018)

Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU
por: Bruyère, Rémi, et al.
Publicado: (2014)

An Observational Study on Early Empiric versus Culture-Directed Antifungal Therapy in Critically Ill with Intra-Abdominal Sepsis
por: Lee, Winnie, et al.
Publicado: (2014)

Prospective Observational Study on the Association Between Serum Mannose-Binding Lectin Levels and Severe Outcome in Critically Ill Patients with Pandemic Influenza Type A (H1N1) Infection
por: Zogheib, Elie, et al.
Publicado: (2017)

Antibodies as Models and Tools to Decipher Candida albicans Pathogenic Development: Review about a Unique Monoclonal Antibody Reacting with Immunomodulatory Adhesins
por: Leroy, Jordan, et al.
Publicado: (2023)

2113. Evaluation of Empiric Antifungal Therapy in Critically Ill Patients with Liver Disease, Sepsis, and No Evidence of Active Fungal Infection
por: Britt, Rachel S, et al.
Publicado: (2019)

Optimal care and design of the tracheal cuff in the critically ill patient
por: Jaillette, Emmanuelle, et al.
Publicado: (2014)

Species Identification and In Vitro Antifungal Susceptibility of Paecilomyces/Purpureocillium Species Isolated from Clinical Respiratory Samples: A Multicenter Study
por: Monpierre, Lorra, et al.
Publicado: (2022)

Intravenous Immunoglobulin Therapy Eliminates Candida albicans and Maintains Intestinal Homeostasis in a Murine Model of Dextran Sulfate Sodium-Induced Colitis
por: Charlet, Rogatien, et al.
Publicado: (2019)

Human Fecal Mucin Glycosylation as a New Biomarker in Inflammatory Bowel Diseases
por: Robbe Masselot, Catherine, et al.
Publicado: (2022)

Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropenia
por: Yu, Donghui T, et al.
Publicado: (2006)

Impact of empirical treatment with antifungal agents on survival of patients with candidemia
por: Poves-Alvarez, Rodrigo, et al.
Publicado: (2019)

Oxidative Stress in the Critically Ill Patients: Pathophysiology and Potential Interventions
por: Makris, Demosthenes, et al.
Publicado: (2018)

Corrigendum: Polymorphisms in the Mannose-Binding Lectin Gene are Associated with Defective Mannose-Binding Lectin Functional Activity in Crohn’s Disease Patients
por: Choteau, Laura, et al.
Publicado: (2016)

Polymorphisms in the Mannose-Binding Lectin Gene are Associated with Defective Mannose-Binding Lectin Functional Activity in Crohn’s Disease Patients
por: Choteau, Laura, et al.
Publicado: (2016)

Ventilator-associated pneumonia in critically ill patients with COVID-19 infection: a narrative review
por: Boyd, Sean, et al.
Publicado: (2022)

Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections
por: Mery, Alexandre, et al.
Publicado: (2016)

Fungal Chitin Reduces Platelet Activation Mediated via TLR8 Stimulation
por: Leroy, Jordan, et al.
Publicado: (2019)

Antifungal prophylaxis in critically ill patients
por: Silvestri, Luciano, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_moq1imu06o8utmkdjrke0i7rh9